Eleni Tsintavi is a Chemical Engineer from the University of Patras, Greece and holds a PhD in the field of Pharmaceutical Technology from the National & Kapodistrian University of Athens, Greece, and is also a holder of a MSc from the department of Life Science & Technology of Delft University of Technology, Netherlands. Her research activity includes the application of 3D printing for the development of pharmaceutical products, the three-dimensional characterization of proteins using liquid chromatography in high throughput mode for the downstream process development as well as the olive mill wastewater pretreatment with ozone in combination with anaerobic digestion. She is currently working in the Research and Development Department of the pharmaceutical company Uni-Pharma S.A. for the development of new pharmaceutical products and production processes, while in the past she has worked in Novartis (Basel, Switzerland), DSM (Delft, Netherlands), Gap Pharmaceuticals (Athens, Greece) and Sustchem Engineering (Athens, Greece).